{
  "doc_id": "Eosinophilia",
  "doc_filename": "Eosinophilia.pdf",
  "top_entities": [
    {
      "name": "eosinophilia-myalgia syndrome",
      "mention_count": 1,
      "entity_type": "disease"
    }
  ],
  "file_size_bytes": 1749,
  "file_size_human": "1.7 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:18",
  "doi": null,
  "doi_url": null,
  "document_type_code": "DLA",
  "document_type_name": "Disease Landscape Analysis",
  "document_type_group": "Disease Landscape Analysis",
  "classification_confidence": 0.85,
  "title": "Eosinophilia-Myalgia Syndrome: Epidemiological Overview",
  "short_description": "Document describing the 1989 epidemic of eosinophilia-myalgia syndrome, including incidence estimates and demographic distribution.",
  "long_description": "This clinical research document provides an epidemiological overview of eosinophilia-myalgia syndrome, focusing on the 1989 epidemic that was first identified in New Mexico. The document discusses the estimated incidence of 5,000-10,000 cases during the epidemic period, noting that the majority of reported cases were among females in the United States. It also mentions the international scope of the syndrome, with cases reported in Germany, Canada, and the United Kingdom, highlighting the global impact of this medical condition.",
  "document_date": "2026-01-07T22:25:18",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T04:20:01.656327"
}